AGL 37.84 Decreased By ▼ -0.16 (-0.42%)
AIRLINK 217.39 Increased By ▲ 3.48 (1.63%)
BOP 9.54 Increased By ▲ 0.12 (1.27%)
CNERGY 6.66 Increased By ▲ 0.37 (5.88%)
DCL 8.70 Decreased By ▼ -0.07 (-0.8%)
DFML 42.65 Increased By ▲ 0.44 (1.04%)
DGKC 95.29 Increased By ▲ 1.17 (1.24%)
FCCL 35.50 Increased By ▲ 0.31 (0.88%)
FFBL 88.94 No Change ▼ 0.00 (0%)
FFL 17.83 Increased By ▲ 1.44 (8.79%)
HUBC 127.70 Increased By ▲ 0.80 (0.63%)
HUMNL 13.87 Increased By ▲ 0.50 (3.74%)
KEL 5.42 Increased By ▲ 0.11 (2.07%)
KOSM 6.93 Decreased By ▼ -0.01 (-0.14%)
MLCF 43.65 Increased By ▲ 0.67 (1.56%)
NBP 59.67 Increased By ▲ 0.82 (1.39%)
OGDC 224.27 Increased By ▲ 4.85 (2.21%)
PAEL 40.00 Increased By ▲ 0.84 (2.15%)
PIBTL 8.29 Increased By ▲ 0.11 (1.34%)
PPL 196.11 Increased By ▲ 4.45 (2.32%)
PRL 38.89 Increased By ▲ 0.97 (2.56%)
PTC 27.50 Increased By ▲ 1.16 (4.4%)
SEARL 105.00 Increased By ▲ 1.00 (0.96%)
TELE 8.75 Increased By ▲ 0.36 (4.29%)
TOMCL 35.45 Increased By ▲ 0.70 (2.01%)
TPLP 13.85 Increased By ▲ 0.97 (7.53%)
TREET 25.45 Increased By ▲ 0.11 (0.43%)
TRG 72.10 Increased By ▲ 1.65 (2.34%)
UNITY 33.35 Decreased By ▼ -0.04 (-0.12%)
WTL 1.72 No Change ▼ 0.00 (0%)
BR100 12,052 Increased By 158.1 (1.33%)
BR30 37,539 Increased By 684 (1.86%)
KSE100 111,643 Increased By 1219.4 (1.1%)
KSE30 35,122 Increased By 343.6 (0.99%)

BEIJING: China will toughen law enforcement to curb monopoly practices and unfair competition in the pharmaceutical industry as the government seeks to foster a good business environment, the industry ministry said on Sunday.

The action follows November's regulatory guidelines to stamp out monopolies in active pharmaceutical ingredients (API).

China leads the world in making and exporting these products.

Despite Covid, it's home or bust for China holiday travellers

In a statement, the ministry of industry and information technology said it would "strengthen law enforcement against unfair competition, and resolutely investigate unfair competitive acts, such as commercial bribery".

It will also stiffen enforcement of anti-monopoly laws in the areas of drug shortages and APIs, prepare and adopt antitrust guidelines in the API market and investigate monopolistic pacts, it added.

Comments

Comments are closed.